coronavirus
spinal
fluid
patient
acut
monosymptomat
optic
neuriti
dessau
rb
lisbi
g
frederiksen
jl
coronavirus
spinal
fluid
patient
acut
monosymptomat
optic
neuriti
acta
neurol
scand
c
munksgaard
acut
monosymptomat
optic
neuriti
amon
may
initi
symptom
multipl
sclerosi
ms
coronavirus
implic
etiolog
ms
object
present
studi
look
coronavir
rna
amon
could
present
initi
stage
develop
ms
materi
method
spinal
fluid
patient
amon
surgic
control
patient
protrus
intervertebr
disk
assay
nest
multiplex
polymeras
chain
reaction
primer
specif
human
coronavirus
strain
hcv
result
four
patient
control
posit
evid
found
frequenc
posit
sampl
low
statist
differ
amon
control
conclus
studi
provid
evid
etiolog
role
human
coronavirus
acut
monosymptomat
optic
neuriti
acut
monosymptomat
optic
neuriti
amon
may
occur
isol
event
often
consid
initi
symptom
multipl
sclerosi
ms
half
patient
convert
clinic
definit
ms
within
year
amon
frequent
last
day
sever
week
may
affect
one
eye
main
symptom
loss
vision
retrobulbar
pain
dyschromatopsia
presenc
human
coronavir
rna
demonstr
brain
tissu
spinal
fluid
patient
clinic
definit
ms
control
investig
possibl
infect
human
coronavirus
hcv
earli
ms
possibl
caus
amon
analyz
cerebrospin
fluid
csf
patient
amon
use
revers
transcriptas
reaction
polymeras
chain
reaction
rtpcr
appli
primer
specif
hcv
csf
obtain
lumbar
punctur
untreat
patient
amon
none
patient
symptom
ms
time
lumbar
punctur
thirtyfour
sampl
obtain
day
median
day
onset
symptom
three
patient
attack
amon
sampl
obtain
relat
first
episod
day
second
episod
amon
patient
differ
eye
involv
patient
eye
thirteen
patient
later
develop
clinic
definit
ms
csf
obtain
surgic
patient
protrus
intervertebr
disc
use
control
median
age
patient
control
amon
rang
rang
year
respect
median
test
p
amon
group
femal
patient
among
control
femal
rtpcr
assay
pool
hcv
neg
spinal
fluid
routin
laboratori
interspers
everi
patient
sampl
includ
throughout
whole
procedur
start
rnaextract
neg
control
steril
water
instead
sampl
ad
enzymat
reaction
start
one
rtreaction
end
second
pcr
inner
set
nest
primer
posit
control
pcr
cell
cultur
supernat
fluid
contain
hcv
strain
atcc
hcv
strain
tcidso
atcc
use
sampl
store
analysi
multiplex
nest
rtpcr
detail
use
use
primer
specif
tabl
rna
extract
perform
lysi
pl
spinal
fluid
serum
vortex
guscnbuff
mm
guanidiniumisothiocyan
mm
dithiothreitol
mm
tri
ph
lsopropanol
pl
ad
vortex
briefli
spun
microcentrifug
g
min
room
temperatur
serum
sampl
complet
remov
supernat
isopropanol
precipit
import
avoid
sticki
protein
precipit
follow
ethanol
step
pellet
pi
ethanol
ad
tube
vortex
precipit
describ
supernat
remov
revers
transcriptas
rt
reaction
perform
mix
primer
reagent
geneamp
rna
pcr
kit
perkin
elmer
cetu
total
volum
pl
concentr
primer
pm
reagent
ad
accord
standard
protocol
includ
kit
mm
x
pcr
buffer
mm
nucleotid
dgtp
datp
dttp
dctp
rnase
inhibitor
revers
transcriptas
incub
perform
min
rnin
less
h
multiplex
pcr
use
specif
primerset
tabl
perform
total
volum
pl
final
concentr
reagent
pcr
includ
reagent
carri
rtreaction
pm
primer
corolo
pm
primer
corol
mm
x
pcr
buffer
mm
nucleotid
dgtp
dutp
dttp
dctp
dnapolymeras
amplitaq
perkin
elmer
cetu
upl
uracilnglycosylas
boehring
mannheim
mm
temperatur
cycl
min
rnin
min
cycl
min
final
soak
one
transfer
inner
pcr
reaction
inner
pcr
reaction
perform
separ
viru
without
repeat
uracilnglycosylas
step
primer
anneal
temperatur
mm
use
primer
corol
anneal
temperatur
mm
use
sensit
pcr
assay
measur
sampl
contain
fold
dilut
viru
contain
cell
cultur
supernat
coronaviru
neg
spinal
fluid
sensit
time
tcidso
pcr
product
visual
electrophoresi
vcm
agaros
follow
southern
blot
nytran
filter
blot
perform
describ
except
setup
invert
overnight
transfer
nytran
filter
paper
rins
briefli
nucleic
acid
immobil
bake
vacuum
h
subsequ
blot
prehybrid
h
follow
hybrid
overnight
dna
fragment
probe
produc
pcr
describ
refer
strain
label
nicktransl
bionick
life
technolog
rockvil
usa
stringent
wash
perform
ssc
ssc
probe
detect
perform
use
photogen
detect
kit
accord
manufactur
instruct
life
technolog
rockvil
usa
pcr
product
sequenc
direct
use
primer
corol
sequenc
primer
cycl
sequenc
reaction
use
primer
corol
use
taq
dyedeoxi
termin
cycl
sequenc
kit
appli
biosystem
perkin
elmer
cetu
connecticut
usa
sequenc
reaction
separ
analyz
appli
biosystem
autom
dna
sequenc
recommend
manufactur
sequenc
edit
seqe
softwar
appli
biosystem
use
align
sequenc
result
done
use
gcg
softwar
packag
csf
patient
control
tabl
posit
nest
rtpcr
use
primer
sampl
neg
primer
amplifi
dna
fragment
visual
hybrid
ethidium
bromid
stain
gel
indic
rna
copi
present
origin
patient
sampl
limit
sensit
assay
ten
interspers
neg
control
pool
spinal
fluid
includ
throughout
procedur
rna
extract
inner
pcr
remain
neg
water
control
ad
enzymat
step
also
remain
neg
amplifi
fragment
base
primer
fig
sequenc
one
patient
frameshift
base
substitut
patient
base
substitut
control
patient
ambigu
sequenc
result
posit
control
consensu
sequenc
base
substitut
compar
publish
sequenc
use
design
primer
howev
ident
anoth
avail
sequenc
gene
knowledg
presenc
human
coronavirus
csf
patient
amon
previous
investig
present
studi
patient
amon
control
posit
none
consid
possibl
fals
posit
result
due
contamin
less
like
uracilnglycosylas
carri
prevent
use
neg
control
consist
neg
sequenc
pcr
product
base
substitut
frameshift
mutat
found
furthermor
control
patient
ambigu
sequenc
result
error
rate
pcr
use
taq
polymeras
estim
nucleotid
less
depend
initi
number
target
copi
reaction
condit
also
rt
step
may
incor
porat
error
templat
pcr
studi
pcr
product
nucleotid
equal
nucleotid
sequenc
fig
differ
found
give
frequenc
mutat
per
base
differ
distinguish
true
genom
variat
experiment
error
pcr
dnasequenc
nucleocapsid
gene
coronavirus
seem
well
conserv
one
publish
sequenc
atcc
type
strain
comparison
bovin
coronaviru
nucleocapsid
gene
show
homolog
code
sequenc
base
differ
base
inner
primer
amplifi
studi
thu
larg
genom
variat
may
expect
even
strain
origin
differ
mammal
speci
concern
two
publish
sequenc
nucleocapsid
gene
atcc
type
strain
close
relat
known
coronavirus
natur
sequenc
variat
clinic
strain
studi
anoth
studi
also
investig
csf
pcrtechniqu
hcv
csf
patient
ms
control
neurolog
diseas
analyz
presenc
human
coronavir
rna
sequenc
studi
found
csf
patient
ms
control
posit
csf
patient
ms
control
posit
thu
total
test
patient
viru
posit
high
frequenc
posit
result
also
control
consist
find
studi
differ
could
explain
differ
sensit
assay
differ
select
control
group
studi
cristallo
et
al
describ
level
sensit
control
group
present
studi
consist
patient
protrus
intervertebr
disk
patient
degen
neurolog
diseas
rna
found
csf
rtpcr
patient
amon
control
frequenc
posit
sampl
low
statist
differ
amon
control
studi
provid
evid
etiolog
role
human
coronavirus
acut
monosymptomat
optic
neuriti
earli
ms
